A detailed history of Franklin Resources Inc transactions in Novartis Ag stock. As of the latest transaction made, Franklin Resources Inc holds 4,377,042 shares of NVS stock, worth $451 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
4,377,042
Previous 5,339,490 18.03%
Holding current value
$451 Million
Previous $568 Million 11.43%
% of portfolio
0.15%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$106.13 - $120.89 $102 Million - $116 Million
-962,448 Reduced 18.03%
4,377,042 $503 Million
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $33.4 Million - $38.7 Million
-360,299 Reduced 6.32%
5,339,490 $568 Million
Q1 2024

May 13, 2024

SELL
$95.27 - $108.47 $20.5 Million - $23.3 Million
-215,200 Reduced 3.64%
5,699,789 $551 Million
Q4 2023

Feb 09, 2024

SELL
$92.27 - $101.54 $27.3 Million - $30.1 Million
-296,103 Reduced 4.77%
5,914,989 $597 Million
Q3 2023

Nov 13, 2023

BUY
$94.73 - $105.13 $2.61 Million - $2.9 Million
27,546 Added 0.45%
6,211,092 $633 Million
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $73.9 Million - $83.8 Million
-798,746 Reduced 11.44%
6,183,546 $624 Million
Q1 2023

May 12, 2023

BUY
$80.03 - $92.81 $22.4 Million - $26 Million
279,999 Added 4.18%
6,982,292 $642 Million
Q4 2022

Feb 10, 2023

SELL
$75.55 - $92.52 $37.6 Million - $46 Million
-497,386 Reduced 6.91%
6,702,293 $608 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $21.5 Million - $25.2 Million
-288,495 Reduced 3.85%
7,199,679 $547 Million
Q2 2022

Aug 11, 2022

BUY
$80.52 - $93.75 $20.8 Million - $24.3 Million
258,830 Added 3.58%
7,488,174 $633 Million
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $153 Million - $173 Million
-1,911,463 Reduced 20.91%
7,229,344 $634 Million
Q4 2021

Feb 11, 2022

BUY
$79.7 - $88.13 $188 Million - $208 Million
2,361,944 Added 34.84%
9,140,807 $800 Million
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $60.8 Million - $70.7 Million
-743,343 Reduced 9.88%
6,778,863 $554 Million
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $78.6 Million - $86.8 Million
-922,205 Reduced 10.92%
7,522,206 $686 Million
Q1 2021

May 13, 2021

SELL
$83.5 - $98.47 $6.31 Million - $7.45 Million
-75,611 Reduced 0.89%
8,444,411 $722 Million
Q4 2020

Feb 10, 2021

BUY
$78.07 - $94.43 $14.8 Million - $17.9 Million
189,509 Added 2.27%
8,520,022 $805 Million
Q3 2020

Nov 12, 2020

SELL
$82.14 - $91.0 $12.7 Million - $14.1 Million
-154,790 Reduced 1.82%
8,330,513 $724 Million
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $32.3 Million - $36.3 Million
-398,937 Reduced 4.49%
8,485,303 $734 Million
Q1 2020

May 13, 2020

SELL
$70.67 - $99.01 $206 Million - $289 Million
-2,914,944 Reduced 24.7%
8,884,240 $733 Million
Q4 2019

Feb 12, 2020

SELL
$84.35 - $95.37 $45.1 Million - $51 Million
-534,300 Reduced 4.33%
11,799,184 $1.12 Billion
Q3 2019

Nov 14, 2019

SELL
$85.54 - $94.26 $135 Million - $148 Million
-1,575,161 Reduced 11.33%
12,333,484 $1.07 Billion
Q2 2019

Aug 14, 2019

SELL
$75.4 - $92.8 $23.2 Million - $28.5 Million
-307,489 Reduced 2.16%
13,908,645 $1.27 Billion
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $869,945 - $995,032
-11,550 Reduced 0.08%
14,216,134 $1.37 Billion
Q4 2018

Feb 12, 2019

SELL
$73.66 - $82.02 $67.6 Million - $75.2 Million
-917,341 Reduced 6.06%
14,227,684 $1.22 Billion
Q3 2018

Nov 13, 2018

SELL
$66.94 - $77.43 $43.5 Million - $50.4 Million
-650,568 Reduced 4.12%
15,145,025 $1.3 Billion
Q2 2018

Aug 14, 2018

BUY
$64.91 - $73.36 $64.6 Million - $73 Million
994,495 Added 6.72%
15,795,593 $1.19 Billion
Q1 2018

May 10, 2018

SELL
$70.39 - $84.15 $2.9 Million - $3.47 Million
-41,236 Reduced 0.28%
14,801,098 $1.2 Billion
Q4 2017

Feb 14, 2018

SELL
$72.33 - $77.64 $50.1 Million - $53.7 Million
-692,263 Reduced 4.46%
14,842,334 $1.25 Billion
Q3 2017

Nov 13, 2017

BUY
$74.14 - $77.27 $1.15 Billion - $1.2 Billion
15,534,597
15,534,597 $1.33 Billion

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.